The synergistic combination of Crataegus pinnatifida and the obesity-related gut microbiota holds promise as a novel therapeutic strategy for obesity by targeting PIK3R1 and modulating the PI3K/Akt signaling pathway. The gene discussed is AKT1; the disease is obesity due to melanocortin 4 receptor deficiency.